Careers  |  Sign In  |  Register

Latest in Hematology-Oncology

Reuters Health • The Doctor's Channel Daily Newscast

Denosumab effective for breast cancer-related bone metastases

NEW YORK (Reuters Health) - Compared with zoledronic acid, the monoclonal antibody denosumab is more effective in delaying skeletal-related events in women with breast cancer that has metastasized to bone, according to the results of a new study. The finding is reported in the November 8 online issue of...

Reuters Health • The Doctor's Channel Daily Newscast

Gefitinib, erlotinib may slow CNS metastases in advanced lung cancer

NEW YORK (Reuters Health) - The tyrosine kinase inhibitors gefitinib or erlotinib may slow the development of central nervous system metastases in patients with advanced non-small cell lung cancer (NSCLC), if they carry sensitizing EGFR mutations. Those findings come from a Boston-based team, reporting in...

Reuters Health • The Doctor's Channel Daily Newscast

Taxane-based breast cancer treatments linked to amenorrhea risk

NEW YORK (Reuters Health) - Women with breast cancer treated with anthracycline-taxane based regimens are more likely to become amenorrheic than women treated with just anthracyclines or conventional chemotherapy, an Iranian study indicates. Dr. Safa Najafi with the Iranian Center for Breast Cancer in...